Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA06 - Resectable and Unresectable Locally Advanced Lung Cancer
- 12:15 - 13:15
- 8/08/2022
- Location: Lehar 1
- Not for CME Credit
- Type: Mini Oral
- Track: Locally Advanced Non-small Cell Lung Cancer
- Moderators:Saulius Cicenas, Celine Mascaux
-
+
Session Moderator
12:16 - 12:17 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
Session Moderator
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.01 - Session Introduction
12:15 - 12:16 | Presenter: Saulius Cicenas
- Abstract
Loading... -
+
MA06.02 - Session Introduction
12:16 - 12:17 | Presenter: Celine Mascaux
- Abstract
Loading... -
+
MA06.03 - Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
12:17 - 12:22 | Presenter: Atocha Romero | Author(s): Roberto Serna, Ernest Nadal, Jose Luis Glez Larriba, Alex Martinez-Marti, Reyes Bernabé, Joaquim Bosch-Barrera, Joaquin Casal, Virginia Calvo, Amelia Insa, Santiago Ponce, Noemi Reguart, Javier De Castro, Bartomeu Massutí, Ramón Palmero, Carlos Aguado de la Rosa, Joaquín Mosquera, Manuel Cobo, Andrés Aguilar, Guillermo López Vivanco, Carlos Camps, Florentino Hernando Trancho, Rafael Lopez-Castro, Teresa Moran, Isidoro Barneto, Delvys Rodriguez-Abreu, Alberto Cruz, Mariano Provencio
- Abstract
Loading... -
+
MA06.04 - Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)
12:22 - 12:27 | Presenter: Motoko Tachihara | Author(s): Kayoko Tsujino, Mototsugu Shimokawa, Takeaki Ishihara, Hidetoshi Hayashi, Yuki Sato, Takayasu Kurata, Shunichi Sugawara, Yoshimasa Shiraishi, Shunsuke Teraoka, Koichi Azuma, Haruko Daga, Masafumi Yamaguchi, Takeshi Kodaira, Miyako Satouchi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
- Abstract
Loading... -
+
MA06.05 - Consolidation Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation for Patients with Unresectable Stage III NSCLC
12:27 - 12:32 | Presenter: Greg Andrew Durm | Author(s): Hirva Mamdani, Sandra Althouse, Salma Jabbour, Apar Kishore Ganti, Shadia Jalal, Jason Alan Chesney, Jarushka Naidoo, Borys Hrinczenko, Mary Jo Fidler, Ticiana Leal, Lawrence Feldman, Naomi Fujioka, Nasser Hanna
- Abstract
Loading... -
+
MA06.06 - Discussant
12:32 - 12:42 | Presenter: Andrea Bille
- Abstract
Loading... -
+
MA06.07 - Molecular Typing of pN2 Lung Adenocarcinoma: A Retrospective Study Based on Transcriptome Sequencing
12:42 - 12:47 | Presenter: Jianfei Zhu | Author(s): Wenchen Wang, Yu Ma, Yanlu Xiong
- Abstract
Loading... -
+
MA06.08 - Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC
12:47 - 12:52 | Presenter: Wilfried Ernst Erich Eberhardt | Author(s): Christoph Poettgen, Thomas Christoph Gauler, Christina Schulte, Godehard Friedel, Hans-Georg Kopp, Berthold Fischer, Heinz Schmidberger, Martin Kimmich, Wilfried Budach, Sebastian Cordes, Martin Metzenmacher, Rodrigo Hepp de los Rios, Werner Spengler, Dirk De Ruysscher, Claus Belka, Stefan Welter, Diana Luetke-Brintrup, Maja Guberina, Filiz Oezkan, Kaid Darwiche, Martin Schuler, Karl-Heinz Joeckel, Clemens Aigner, Georgios Stamatis, Martin Stuschke
- Abstract
Loading... -
+
MA06.09 - Deep Learning for Predicting MPR to Neoadjuvant Immunotherapy in NSCLC
12:52 - 12:57 | Presenter: Yifan Zhong | Author(s): Yunlang She, Jiajun Deng, Chang Chen
- Abstract
Loading... -
+
MA06.10 - Discussant
12:57 - 13:07 | Presenter: Dawn Owen
- Abstract
Loading... -
+
MA06.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...